(PharmaNewsWire.Com, July 20, 2017 ) According to Publisher, the Global Biodegradable Stents market is accounted for $0.47 billion in 2016 and is expected to reach $3.51 billion by 2022 growing at a CAGR of 39.8% during the forecast period 2016 to 2022. The prevailing usage of stents in treatment of artery disease is rapidly providing market growth. Patients demand for minimal invasive surgeries, growing geriatric population and technological advancements are some of the factors driving market. However, safety & regulatory issues and cost issues are some reasons behind the market lag.
Hospitals segment is expected to dominate the market, it is because of majority hospitals procuring medical products and consumables in bulk. Moreover, coronary artery disease is expected to dominate application segment on account of growing geriatric population and rising consequences of disease occurring. In geographical segment, North America is estimated to dominate the market due to high prevalence of cardiovascular diseases. In addition to that, Asia Pacific market is expected to grow at highest CAGR attributing to growing awareness about Bioabsorbable stents.
Some of the key players of the Biodegradable Stents market include Abbott Laboratories, Amaranth Medical, Inc., Arterial Remodeling Technologies SA, Arterius Limited, BIOTRONIK SE & Co. KG, Biotronik, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Meril Life Sciences, REVA Medical, Inc., SMT (Part of Sahajanand Group of Companies) , Tepha, Inc. and Xenogenics Corporation.
Regions Covered: -North America-US-Canada-Mexico -Europe-Germany-France-Italy-UK -Spain -Rest of Europe -Asia Pacific-Japan-China-India-Australia-New Zealand-Rest of APAC -Rest of the World-Middle East-Brazil-Argentina-South Africa-Egypt
Company Profiling 12.1 Abbott Laboratories 12.2 Amaranth Medical, Inc. 12.3 Arterial Remodeling Technologies SA 12.4 Arterius Limited 12.5 BIOTRONIK SE & Co. KG 12.6 Biotronik 12.7 Elixir Medical Corporation 12.8 Kyoto Medical Planning Co., Ltd. 12.9 Meril Life Sciences 12.10 REVA Medical, Inc. 12.11 SMT (Part of Sahajanand Group of Companies) 12.12 Tepha, Inc. 12.13 Xenogenics Corporation
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
